J0701 Cefepime (HCPCS) Reimbursement & Policy | OpenPayer

Summary & Overview

HCPCS J0701: Cefepime Hydrochloride (Baxter) Injection, 500 mg

HCPCS Level II code J0701 identifies a 500 mg vial of cefepime hydrochloride (Baxter), an injectable fourth-generation cephalosporin specified as not therapeutically equivalent to Maxipime. This billing code covers the drug product itself and is used when cefepime is supplied for parenteral administration in acute and outpatient settings. Nationally, antibiotic drug codes like J0701 matter for hospital pharmacy procurement, outpatient infusion billing, and antimicrobial stewardship because they affect drug cost reporting, reimbursement flows, and claims processing for serious bacterial infections.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical role and common sites of service, benchmarks for coverage and reimbursement practices, and notes on billing considerations tied to drug identity and non-equivalence status. The publication summarizes payer coverage patterns, common billing modifiers used in practice, and implications for facility and outpatient claims. Data limitations where input data are not provided are noted as "Data not available in the input."

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ0701HCPCS Level IIcefepimeinjectable antibioticdrug billinghospital outpatientinfusion centerantimicrobial stewardshippharmacy billing

Billing Code Overview

HCPCS Level II code J0701 represents injection of cefepime hydrochloride (Baxter), 500 mg, specified as not therapeutically equivalent to Maxipime. The service is the provision of an intravenous or intramuscular antibiotic administration product used for treatment of serious bacterial infections where cefepime is indicated.

Service type: Injectable antibiotic medication
Typical site of service: Hospital inpatient, hospital outpatient, emergency department, or other settings where parenteral antibiotics are administered (e.g., infusion centers)

Clinical & Coding Specifications

Clinical Context

A 68-year-old male with a history of type 2 diabetes mellitus and chronic obstructive pulmonary disease presents to the emergency department with fever, productive cough, and shortness of breath. Chest radiograph demonstrates a right lower lobe consolidation consistent with community-acquired pneumonia complicated by suspected gram‑negative infection. Blood cultures are pending. The admitting hospitalist and infectious disease consultant decide to start empiric broad-spectrum intravenous therapy with cefepime. Pharmacy dispenses J0701 (cefepime hydrochloride, 500 mg) for reconstitution and administration. Nursing documents dose, route (intravenous), infusion time, lot number, and any immediate adverse reactions. Subsequent orders include renal function monitoring and dose adjustment if creatinine clearance declines. The clinical workflow includes order entry by the provider, pharmacist verification, medication preparation in the pharmacy or at bedside, administration by a registered nurse, and documentation in the electronic health record.

Coding Specifications

Modifier	Description	When to Use
`00`	Unmodified service	When no modifier applies and service is billed in standard fashion.
`22`

Related Codes

HCPCS-J3090-TEDIZOLID-INJECTION-1MG

HCPCS Level II J3090: Injection, tedizolid phosphate, 1 mg

HCPCS-J2180-MEPERIDINE-PROMETHAZINE-INJECTION-UP-TO-50-MG

HCPCS J2180: Injection, Meperidine and Promethazine HCl, up to 50 mg

HCPCS-J1710-HYDROCORTISONE-INJECTION-50MG

HCPCS Level II J1710: Hydrocortisone Sodium Phosphate Injection, up to 50 mg

HCPCS-J0165-EPINEPHRINE-INJECTION-0-1-MG

HCPCS J0165: Epinephrine Injection, 0.1 mg

HCPCS-J0285-AMPHOTERICIN-B-50MG-INJECTION

HCPCS J0285: Injection, Amphotericin B, 50 mg

HCPCS-J7627-BUDESONIDE-INHALATION-SOLUTION-COMPOUNDED-DME-UNIT-DOSE-0-5MG

HCPCS J7627: Budesonide Inhalation Solution, Compounded, DME Unit Dose

HCPCS-J1096-DEXAMETHASONE-LACRIMAL-OPHTHALMIC-INSERT-0-1-MG

HCPCS Level II J1096: Dexamethasone Lacrimal Ophthalmic Insert, 0.1 mg

HCPCS-J7190-FACTOR-VIII-ANTIHEMOPHILIC-FACTOR-HUMAN-PER-IU

HCPCS J7190: Factor VIII (Antihemophilic Factor, Human) per I.U.

HCPCS-J8600-MELPHALAN-ORAL-2MG

HCPCS Level II J8600: Melphalan Oral 2 mg

HCPCS-J0650-LEVOTHYROXINE-INJECTION-10-MCG

HCPCS Level II J0650: Injection, Levothyroxine Sodium, 10 mcg

Showing 1–10 of 991

Taxonomy Code	Specialty	Notes
`207Q00000X`	Infectious Disease	Physicians who order and manage parenteral broad‑spectrum antibiotics.
`207L00000X`	Internal Medicine	Hospitalists and internists who commonly initiate inpatient IV antibiotic therapy.
`163W00000X`	Emergency Medicine	Providers who often initiate empiric IV cefepime in the ED prior to admission.
`364S00000X`	Clinical Nurse Specialist	Advanced practice clinicians involved in medication management and infusion oversight.
`363L00000X`	Registered Nurse	Nurses who administer IV medications and document infusion details.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J18.9`	Pneumonia, unspecified organism	Common indication for empiric broad‑spectrum IV cefepime when bacterial pneumonia is suspected.
`J15.9`	Bacterial pneumonia, unspecified	Direct bacterial pneumonia diagnosis that supports IV antibiotic therapy.
`A41.9`	Sepsis, unspecified organism	Severe systemic infection where broad‑spectrum IV antibiotics like cefepime are often used empirically.
`N39.0`	Urinary tract infection, site not specified	Complicated UTIs with suspected gram‑negative organisms may require IV cefepime.
`K65.9`	Peritonitis, unspecified	Intra‑abdominal infections with gram‑negative pathogens that may be treated with cefepime.
`H66.9`	Otitis media, unspecified	Less common, but complicated infections caused by resistant gram‑negative organisms may prompt IV therapy.
`M00.9`	Pyogenic arthritis, unspecified	Joint infections due to gram‑negative organisms can require IV cefepime.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used to report the infusion/administration of the first hour of IV antibiotic therapy in outpatient or infusion center settings when applicable.
`96366`	Intravenous infusion, each additional hour	Used when infusion extends beyond the initial hour and per payer guidance for prolonged administrations.
`96374`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); when administered by a physician or other qualified health care professional, subcutaneous or intramuscular	May apply for single IM or SC injections if cefepime were given via those routes (cefepime typically IV).
`36415`	Collection of venous blood by venipuncture	Commonly performed for baseline and monitoring labs (renal function, drug levels if indicated) associated with IV cefepime therapy.
`73110`	Radiologic exam, chest, single view, frontal	Often performed as part of the diagnostic workup for suspected pneumonia prior to initiating broad‑spectrum IV antibiotics.